The proof-of-concept, which will be exhibited at the Singapore Fintech Festival from Nov. 6-8, demonstrates how investors could settle multi-asset positions in real-time.
The studies highlighted in the publication, titled " An in vitro and in vivo efficacy evaluation of a novel gene therapy candidate (SBT101) in mouse models of adrenomyeloneuropathy and in NHPs ,” ...